Private Market View

Neurosight

London, United Kingdom · Founded 2019 · Privately Held (backing)

Last price · $/share
Implied valuation
$6.5M
Total raised
$1.1M
Last round

Key facts

  • Neurosight’s last known valuation is $6.5M (Jan 2025).
  • It has raised $1.1M; the latest was Later Stage VC ($280K) in Dec 2025.
  • Notable investors include Creative Destruction Lab, SFC Capital, MassLight.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 3 names
  • ·Watchlist + deal alerts for Neurosight
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Neurosight are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Neurosight

Operator of an online assessment platform intended to identify the strengths, competencies, development areas, and weaknesses of every candidate. The company's platform offers talent assessment by combining traditional business psychology with the latest advances in neuroscience to create a fair and accurate talent assessment, enabling customers to have a platform that delivers meaningful feedback.

Sector
Consumer Products and Services (B2C)
HQ
London, United Kingdom
Founded
2019
Employees
13
Ownership
Privately Held (backing)
PA Mark — not yet priced

Neurosight doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Neurosight shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Neurosight in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.